Navigation Links
ERT to Present at the UBS 20th Annual Global Healthcare Services Conference on February 8, 2010
Date:2/1/2010

PHILADELPHIA, Feb. 1 /PRNewswire-FirstCall/ -- ERT (Nasdaq: ERES), announced today that Dr. Michael J. McKelvey, the Company's President and CEO, and Keith Schneck, the Company's Executive Vice President and CFO, are scheduled to present at the UBS 20th Annual Global Healthcare Services Conference at 3:30 PM EST on February 8, 2010 in New York City.

Interested parties may access the presentation by visiting the Company's corporate website at http://www.ert.com.  The webcast may also be accessed at http://cc.talkpoint.com/ubsx001/020810a_ke/?entity=33_YR2H1UU.  The webcast will be available via replay for 90 days.

About ERT

Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com) is a global provider of technology and services to the biopharmaceutical, medical device, and related industries. The Company is the market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate
'/>"/>

SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sangamo BioSciences Announces Presentation at BIO CEO & Investor Conference
2. Telik Announces Presentation and Webcast at 12th Annual BIO CEO & Investor Conference
3. NOVAVAX to Present at Phacilitate Vaccine Forum Washington 2010
4. NeurogesX to Present at J.P. Morgan Health Care Conference
5. Poniard Pharmaceuticals, Inc. to Present Additional Cancer Treatment Data Found Significant by TapeBeat.Com Investors
6. Oxygen Biotherapeutics, Inc. Outlines Plans for New Products During Investor Conference Presentation
7. Resverlogix Presenting at Biotech Showcase
8. Amira Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
9. Profectus Biosciences to Present at Key Investor Conference in January 2010
10. Sinovacs CEO Weidong Yin Presented with Annual Innovation Award by China Central Television
11. Institut Paoli Calmettes and Ipsogen Presented a New Study Supporting the Pivotal Role of Tumor Grade in Chemotherapy Prescription at the 32nd Annual San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 The Oklahoma tornado ... following its ravage, the mayor of Moore, one of the ... houses, said a report from cnn.com. Reaching out to also ... complimentary Molderizer and Safe Shield to counter the looming mold ... published on May 22, 2013, caused 24 deaths, My Cleaning ...
(Date:5/24/2013)... Quincy Bioscience, a leading research company ... proteins to support healthy living, is pleased to ... apoaequorin in Food and Chemical Toxicology ... Industrial Biological Research Association. , The objective ... effects, if any, of apoaequorin, in rats following ...
(Date:5/23/2013)... stopped breathing, his collapsed bronchus blocking the crucial flow ... watched helplessly, just praying that somehow the dire predictions ... had a good chance of not leaving the hospital ... Kaiba. "At that point, we were desperate. Anything that ... it." , They found hope at the University of ...
(Date:5/23/2013)... 23, 2013  BioScrip, Inc. (NASDAQ: BIOS ... the Jefferies 2013 Global Healthcare Conference to be held ... Richard Smith , President ... , Chief Financial Officer, will present on Monday, ... About BioScrip BioScrip, Inc. provides ...
Breaking Biology Technology:Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3
... HARBIN, China, Aug. 8 /Xinhua-PRNewswire-FirstCall/ -- China ... Yingxia" or "the,Company"), a leading provider in ... and distribution of organic nutritional food,products, supplements, ... Republic,of China ("PRC"), announced today it will ...
... 8 Centocor, Inc., today announced,that the U.S. ... review,timeline for the Biologic License Application for ustekinumab, ... 2008. The,application, filed by Centocor late in 2007, ... adult patients with chronic moderate to,severe plaque psoriasis., ...
... 8 Carna Biosciences, Inc. ("Carna"),is pleased to ... Life Sciences, Inc. USA ("Caliper") on August 6 ... of discrete protein kinases aiding,the expansion of Caliper,s ... Selectivity Assay Kits. Caliper,s products and,services are widely ...
Cached Biology Technology:China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results 2FDA Extends Review Timeline for Ustekinumab Biologic License Application Three Months 2Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences 2
(Date:5/24/2013)... In recent years, microRNAs (miRNAs) and other non-coding ... expression of specific proteins. In recent years they ... been used to establish tissue origin for cancers ... responses and screen for disease, but clinically tractable, ... samples are not currently available. In this issue ...
(Date:5/23/2013)... said to be the world,s most popular fruit, can ... research with purple GM varieties. , "Working with ... by the addition of a specific compound, allows us ... said Professor Cathie Martin from the John Innes Centre. ... with better flavour, health and shelf life characteristics because ...
(Date:5/23/2013)... tight wrapping of genomic DNA around nucleosomes in ... expression. A team of Ludwig-Maximilians-Universitaet (LMU) in Munich ... to be locally displaced from nucleosomes for transcription. ... stored in the cell nucleus, wrapped around disk-shaped ... of four different histone proteins and accommodating two ...
Breaking Biology News(10 mins):The world's favorite fruit only better-tasting and longer-lasting 2Biochemistry: Unspooling DNA from nucleosomal disks 2
... Vaccine Advocacy Coalition (AVAC) today urged Dr. Anthony Fauci and ... to act swiftly to clarify the path ahead suggested by ... proposed PAVE 100 AIDS vaccine trial but would, instead, consider ... on leaders in the field to make clear commitments of ...
... researchers found a new protein produced excessively in malignant ... cancer rates climb dramatically among young women. The ... is increased in the most dangerous types of skin ... be difficult to predict called thin melanomas. The finding ...
... YORK July, 16, 2008 When it comes to ... us. Our immune systems respond to foreign substances with ... they,ve encountered in the past. Normally, anything previously identified as ... goes awry, triggering an allergic reaction. , ...
Cached Biology News:AVAC comments on NIAID decision not to move forward with PAVE 100 Trial 2AVAC comments on NIAID decision not to move forward with PAVE 100 Trial 3As rates rise, researchers find better way to identify melanoma 2As rates rise, researchers find better way to identify melanoma 3Asthma and other allergies tied to absence of specialized cells 2Asthma and other allergies tied to absence of specialized cells 3
Request Info...
Request Info...
Request Info...
Ready for formulation or direct injection into animals Provided in convenient 100, 250, 1000 and 10,000 nmol sizes HPLC purified, salt free, sterile filtered, and endotoxin tested ...
Biology Products: